Skip to content

Analysis of oral microbeta in oral cancer patients

Analysis of oral microbeta in oral cancer patients - Analysis of oral microbeta in oral cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032093
Enrollment
300
Registered
2018-04-04
Start date
2016-10-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral cancer

Interventions

Sponsors

Tsurumi University
Lead Sponsor
National Institutes of Biomedical Innovation, Health and Nutrition Southern TOHOKU Research Institute for Neuroscience Southern TOHOKU General Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Oral cancer patients and non-cancer patients.

Exclusion criteria

Exclusion criteria: The people can not follow instructions ,low secretional capacity of saliva . The people received chemotherapy and radiation. The people were adoministrated antimicrobial agent up to 28days.

Design outcomes

Primary

MeasureTime frame
Fungal species,Microbiota,The number of fungi, Concentration of each antimicrobial protein and antibody(Defensin,SLPI,Lactoferrin,Histatins,sIgA),Low-molecular substance

Secondary

MeasureTime frame
Age,Sex,Histoey of present illnesss,Past medical History ,Oral examination

Countries

Japan

Contacts

Public ContactTomoko Ohshima

Tsurumi University School of Dental Medicine Oral Microbiology

ohshima-t@fs.tsurumi-u.ac.jp045-580-8441

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026